Rosacea: Pathogenesis and Therapeutic Correlates.
Geng RSQ, Bourkas AN, Mufti A, Sibbald RG.
J Cutan Med Surg. 2024 Mar-Apr;28(2):178-189. doi: 10.1177/12034754241229365. Epub 2024 Mar 7.
Granulomatous rosacea.
Sánchez JL, Berlingeri-Ramos AC, Dueño DV.
Am J Dermatopathol. 2008 Feb;30(1):6-9. doi: 10.1097/DAD.0b013e31815bc191.
Rosacea.
Searle T, Al-Niaimi F, Ali FR.
Br J Hosp Med (Lond). 2021 Feb 2;82(2):1-8. doi: 10.12968/hmed.2020.0417. Epub 2021 Feb 27.
Neurogenic Rosacea Treatment: A Literature Review.
Ivanic MG, Oulee A, Norden A, Javadi SS, Gold MH, Wu JJ.
J Drugs Dermatol. 2023 Jun 1;22(6):566-575. doi: 10.36849/JDD.7181.
Rosacea: Diagnosis and Treatment.
Oge' LK, Muncie HL, Phillips-Savoy AR.
Am Fam Physician. 2015 Aug 1;92(3):187-96.
Recent advances in understanding and managing rosacea.
Buddenkotte J, Steinhoff M.
F1000Res. 2018 Dec 3;7:F1000 Faculty Rev-1885. doi: 10.12688/f1000research.16537.1. eCollection 2018.
Granulomatous Rosacea and Periorificial Dermatitis: Controversies and Review of Management and Treatment.
Lee GL, Zirwas MJ.
Dermatol Clin. 2015 Jul;33(3):447-55. doi: 10.1016/j.det.2015.03.009.
Therapeutic strategies focusing on immune dysregulation and neuroinflammation in rosacea.
Tu KY, Jung CJ, Shih YH, Chang ALS.
Front Immunol. 2024 Jul 29;15:1403798. doi: 10.3389/fimmu.2024.1403798. eCollection 2024.
Granulomatous rosacea in Chinese patients: Clinical-histopathological analysis and pathogenesis exploration.
Jiang Y, Huang Y, Ma G, Liu T, Li Q, Wu H, Li J.
J Dermatol. 2023 Jul;50(7):856-868. doi: 10.1111/1346-8138.16767. Epub 2023 Apr 5.
[Rosacea].
Huldt-Nystrøm T, Danielsen K, Li X, Stangeland KZ.
Tidsskr Nor Laegeforen. 2017 Oct 2;137(18). doi: 10.4045/tidsskr.16.0657. Print 2017 Oct 3.
